ASH Clinical News ACN_4.1_FULL_ISSUE_DIGITAL | Page 75

Check out the new and improved
ASHClinicalNews.org!
SLEEKER
DESIGN,
EASIER
NAVIGATION
QUICKLY FIND THE
LATEST NEWS ...
NOW APPROVED
PREVYMIS
TM
(letermovir)
240 mg, 480 mg tablets
Injection 20 mg/mL
AND EASILY BROWSE
THE PRINT ISSUE!
Learn more at www.prevymis.com/hcp
Copyright © 2017 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
All rights reserved. AINF-1215030-0000 11/17